Vertex Pharmaceuticals | Creditori Commerciali

Prezzo Delle Azioni
470.52
Cambio Giornaliero
4.91 1.05%
Mensile
4.84%
Annuale
-3.67%
Q1 Previsione
455.43




Creditori Commerciali Cambiamento Data
AbbVie USD 32.25B 1.2B 2025-06
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Agios Pharmaceuticals USD 19.55M 2.02M 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Amgen USD 19.64B 1.61B 2025-09
Arrowhead Research USD 17.67M 15.38M 2025-09
Biogen USD 413.1M 4.7M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Gilead Sciences USD 808M 226M 2025-09
Incyte USD 171.92M 1.24B 2025-09
Insmed USD 79.59M 1.24M 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 9.62B 161M 2025-09
Merck USD 4.15B 102M 2025-09
Moderna USD 267M 92M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 468M 36M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


Vertex Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.